Events, By Category and Date:
» Go to news mainAppointment to Canada's Patented Medicine Prices Review Board
Posted by nte on
July 5, 2018
in
In Action
Matthew Herder
Official statement by Her Excellency the Governor General in Council, on the recommendation of the Minister of Health, pursuant to section 91 of the Patent Act, appointing Matthew Herder of Dartmouth, Nova Scotia, to be a member of the Patented Medicine Prices Review Board, to hold office during good behaviour for a period of five years.
Media coverage
Poirer, R. (5 July 2018). Two Dal faculty members appointed to Canada's Patented Medicine Price Review Board. Dal News.
Recent News
- On what basis did Health Canada approve OxyContin in 1996? A retrospective analysis of regulatory data
- Matthew Herder Resigns from Patented Medicine Prices Review Board
- Permissive regulation: A critical review of the regulatory history of buprenorphine formulations in Canada
- Fair pricing of “old” orphan drugs: considerations for Canada’s orphan drug policy
- Podcast or Perish: Episode 040: Françoise Baylis
- Bioethicist Françoise Baylis asks why humans think 'they can just take everything'
- Killam Prize winners discuss research in Canada
- World‑renowned Dalhousie bioethicist and battery pioneer win prestigious Killam Prize